PRIA Logo™
119-hr-8763119th CongressWALLET

TREAT PTSD VA Act

Sponsored By: Representative Perry, Scott [R-PA-10]

Introduced

Summary

This bill would direct the Department of Veterans Affairs to offer stellate ganglion block (SGB) to enrolled veterans with PTSD who choose it after informed consent. It would also require the VA to update the VA/DoD clinical guideline for PTSD to reflect SGB as a therapy option and to include clinical indicators and contraindicators within 180 days.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

New PTSD treatment option for veterans

If enacted, the bill would require the VA to provide stellate ganglion block (SGB) therapy to certain veterans with PTSD. You would be eligible if you are enrolled in the VA patient enrollment system under 38 U.S.C. §1705, have a PTSD diagnosis, and elect SGB after a qualified provider explains the risks and benefits. The VA could furnish SGB at a VA medical facility or through a provider designated under 38 U.S.C. §1703(c). The amendment creating coverage would take effect 180 days after enactment. The VA would also have 180 days after enactment to update the VA/DoD PTSD clinical guideline to list SGB and include clinical indicators and contraindications, and then notify the House and Senate Veterans' Affairs Committees.

Sponsors & CoSponsors

Sponsor

Perry, Scott [R-PA-10]

PA • R

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation